Cargando…
Characterization of the Xiamenmycin Biosynthesis Gene Cluster in Streptomyces xiamenensis 318
Xiamenmycin (1) is a prenylated benzopyran derivative with anti-fibrotic activity. To investigate the genetic basis of xiamenmycin biosynthesis, we performed genome mining in the xiamenmycin-producing Streptomyces xiamenensis wild-type strain 318 to identify a candidate gene cluster. The complete ge...
Autores principales: | Yang, Yong, Fu, Ling, Zhang, Jinlong, Hu, Linghan, Xu, Minjuan, Xu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053376/ https://www.ncbi.nlm.nih.gov/pubmed/24919072 http://dx.doi.org/10.1371/journal.pone.0099537 |
Ejemplares similares
-
Deciphering the streamlined genome of Streptomyces xiamenensis 318 as the producer of the anti-fibrotic drug candidate xiamenmycin
por: XU, Min-Juan, et al.
Publicado: (2016) -
Dynamical modelling of secondary metabolism and metabolic switches in Streptomyces xiamenensis 318
por: Zhu, Xiao-Mei, et al.
Publicado: (2019) -
Correction to: ‘Dynamical modelling of secondary metabolism and metabolic switches in Streptomyces xiamenensis 318’
por: Zhu, Xiao-Mei, et al.
Publicado: (2019) -
Kinetic model of metabolic network for xiamenmycin biosynthetic optimisation
por: Xu, Min‐juan, et al.
Publicado: (2016) -
Structural diversity of anti-pancreatic cancer capsimycins identified in mangrove-derived Streptomyces xiamenensis 318 and post-modification via a novel cytochrome P450 monooxygenase
por: Yu, He-Lin, et al.
Publicado: (2017)